These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9013404

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Wearing-off phenomenon--neurological approach].
    Ishikawa A.
    Nihon Rinsho; 2000 Oct; 58(10):2100-3. PubMed ID: 11068454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off].
    Bokor M, Szentesi A.
    Ideggyogy Sz; 2010 Jul 30; 63(7-8):247-51. PubMed ID: 20812452
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T, Machado R, Rocha JF, Fernandes-Lopes C, Costa R, Torrão L, Loureiro AI, Falcão A, Vaz-da-Silva M, Wright L, Almeida L, Soares-da-Silva P.
    Clin Ther; 2009 Oct 30; 31(10):2258-71. PubMed ID: 19922897
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.
    Khor SP, Hsu A.
    Curr Clin Pharmacol; 2007 Sep 30; 2(3):234-43. PubMed ID: 18690870
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study].
    Chaná P, Fierro A, Reyes-Parada M, Sáez-Briones P.
    Rev Med Chil; 2003 Jun 30; 131(6):623-31. PubMed ID: 12942590
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of levodopa.
    Nutt JG.
    Mov Disord; 2008 Jun 30; 23 Suppl 3():S580-4. PubMed ID: 18781675
    [Abstract] [Full Text] [Related]

  • 19. The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa.
    Reuter I, Harder S, Engelhardt M, Baas H.
    Mov Disord; 2000 Sep 30; 15(5):862-8. PubMed ID: 11009191
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.